Ashwagandha KSM-66 vs Generic Ashwagandha: What the Studies Actually Say

A system that understood this transition three thousand years before we named it

Ayurveda is not a wellness aesthetic. It is not a retreat in Bali or a turmeric latte philosophy. It is a complete system of medicine, codified in Sanskrit texts that predate most of Western pharmacology by several millennia, built on precise observation of the human body, its rhythms, its constitutions, and the way it changes across a lifetime.

Anne-Gaëlle, Vivana’s co-founder, is a pharmacist. She is also trained in Ayurvedic lifestyle, not as a spiritual practice, but as an extension of the same intellectual curiosity that took her into pharmacy in the first place. A commitment to understanding how the body actually works, and what traditional medicine systems, when taken seriously rather than romantically, have to teach a modern formulator.

Her view, which informs how Vivana thinks about midlife: if a medical system has been observing the same transition in the same bodies for six thousand years and reaching consistent conclusions, that is data. Not folklore. Data.

And what Ayurveda has been saying about the menopausal transition for six thousand years is, in retrospect, remarkably precise.

The Pitta-to-Vata shift: what Ayurveda actually describes

Ayurvedic medicine organises the body and its phases of life through three primary constitutions, or doshas, each representing a combination of elemental qualities that govern physiology and temperament.

Kapha (earth and water) dominates youth. It is the dosha of growth, density, stability. The body at its most physically abundant.

Pitta (fire and a touch of water) governs the productive years. Pitta is the dosha of transformation, drive, precision. It runs hot. It gets things done. It is the constitution of someone in the middle of their career, their family, their life, metabolising everything at full capacity.

Vata (air and space) governs the later decades. Vata is light, mobile, quick. It is also drying, dispersing, and when it accumulates in excess, destabilising.

The menopausal transition, in Ayurvedic understanding, is the shift from Pitta dominance to Vata dominance. And here is where the aha moment tends to arrive.

Hot flushes and inflammation: that is Pitta, the fire dosha, flaring as it yields dominance. The heat has nowhere to go and no hormonal infrastructure to regulate it.

The 3am wake-up, the racing mind, the inability to settle, the anxiety that arrives without cause, the dryness: that is Vata accumulating. Air in excess creates exactly that pattern: movement without direction, activity without rest, a nervous system that cannot find stillness.

The tired-and-wired state (the exhaustion that coexists with an inability to switch off) is both doshas simultaneously. The residual Pitta fire keeping the system activated, the incoming Vata amplifying the nervous system’s sensitivity. Two climates competing in the same body.

Western endocrinology arrived at the same cluster of symptoms (oestrogen decline disrupting HPA axis regulation, progesterone loss destabilising sleep, cortisol dysregulation amplifying the whole picture) with considerably more recent technology and considerably more expensive instruments. The map is different. The territory is the same.

Where ashwagandha fits in this picture

Ashwagandha (Withania somnifera) has been used in Ayurvedic medicine for over three thousand years. Its Sanskrit name translates roughly as ‘smell of horse’: not a marketing triumph, but a reference to the strength and vitality the root was believed to confer.

In Ayurvedic classification, ashwagandha is a rasayana: a rejuvenating tonic used to restore ojas, the vital essence that governs resilience, immunity and the capacity to recover. It is specifically indicated for Vata disorders: anxiety, disrupted sleep, nervous exhaustion, the depletion that follows sustained stress. It pacifies Vata without significantly aggravating Pitta, making it particularly well-suited to the transition phase.

The traditional preparation used the whole root. Dried, powdered, typically taken with warm milk and honey in the evening. Not a capsule. Not a standardised extract. But the therapeutic intent is recognisable across three thousand years of consistent use: build resilience, support the nervous system, help the body recover from depletion.

This is the Ayurvedic model of an adaptogen. Not erasing symptoms. Building the capacity to meet the conditions that produce them.

That framing (resilience over suppression, building capacity rather than fixing dysfunction) is precisely how Vivana thinks about supplementation. Not a patch. Not a pharmaceutical substitute. A signal to a system that it is supported.

From rasayana to randomised controlled trial: the modern evidence

Here is where we shift registers. The Ayurvedic framework explains why ashwagandha has been used for this purpose for millennia. The clinical research explains whether the mechanism holds under controlled conditions, in quantifiable terms, with modern analytical methods.

The short answer is: it does. With one important qualification.

Not all ashwagandha is the same. The qualification matters enormously.

The extract question: why KSM-66 is not just a marketing badge

Ashwagandha is a root. The root contains dozens of active compounds (primarily withanolides, alkaloids and sitoindosides) whose concentrations vary significantly depending on where the plant was grown, when it was harvested, which part of the plant was used, and how it was extracted.

Generic ashwagandha supplements on the market range from whole root powder (low, variable withanolide content) to leaf extracts (different compound profile, different activity) to blended plant-part extracts with unstandardised or undisclosed withanolide levels. A label that says “ashwagandha extract 300mg” tells you almost nothing about what’s actually in the capsule.

Clinical trials are conducted on specific, characterised extracts. When a study reports that ashwagandha reduced serum cortisol by a statistically significant margin, that finding applies to the extract used in that study. It cannot be assumed to apply to a generic alternative with a different plant part, extraction method, or withanolide concentration.

This is not a technicality. It is the fundamental reason why supplement research so often disappoints in practice: people buy the ingredient name, not the form the evidence was built on.

What KSM-66 actually is

KSM-66 is a full-spectrum ashwagandha root extract produced by Ixoreal Biomed, standardised to a minimum 5% withanolides using a proprietary water-based extraction process. No alcohol or chemical solvents. Full-spectrum means the extract preserves the natural ratio of compounds found in the root, rather than isolating a single constituent. This is significant because the withanolides work synergistically, and whole-root preparations have been the basis of Ayurvedic use for three thousand years.

It is produced exclusively from the root: not leaves, not whole plant. This matters because the root contains the highest concentration of the therapeutically relevant withanolides, and because the traditional use that built the evidence base was always root-based.

As of 2024, KSM-66 has been the subject of more than 22 gold-standard clinical trials (randomised, double-blind, placebo-controlled), making it among the most clinically substantiated ashwagandha extracts available anywhere in the supplement market.

What those trials have examined

What generic ashwagandha offers instead

Lower unit cost. That is the primary advantage. Without standardisation to a characterised extract, without independent clinical trials on the specific product, and without verified withanolide content, the clinical evidence above simply does not transfer. You may be taking ashwagandha root powder. You may not be taking anything meaningfully close to the compound profile that produced those results.

Some generic extracts are standardised, but to 2.5% withanolides, or to a different marker, or using a leaf-and-root blend that doesn’t reflect the trial preparations. The label requires scrutiny. The question to ask of any ashwagandha product is not ‘does it contain ashwagandha?’ but ‘which extract, standardised to what, at what dose, supported by which evidence?’

Why KSM-66 is in Cortisol Control, and why at 200mg

Cortisol Control contains KSM-66 at 200mg per daily serving, consistent with the dose range used across the clinical trial literature. Not the maximum possible dose crammed into a label claim. The dose the evidence supports.

It sits alongside phosphatidylserine (250mg, studied for cortisol response blunting), L-Theanine (100mg, for nervous system downregulation), glycine (200mg, for sleep quality), GABA (100mg), holy basil (200mg, a second adaptogenic layer), taurine (300mg, for nervous system support), and Vitamin B6 as P5P (which contributes to normal psychological function and normal nervous system function) at 5mg.

Each ingredient addresses a different mechanism in the cortisol-stress-sleep cluster. The ashwagandha works on the HPA axis and cortisol response over time. The phosphatidylserine works on the acute cortisol spike. The L-Theanine and glycine work on the evening nervous system transition. The vitamin B6 supports the neurotransmitter synthesis that underpins all of it.

This is what Ayurveda would recognise as a rasayana approach: multiple inputs, each supporting a different aspect of the same underlying depletion. Not one magic herb. A system.

The thing about six thousand years of observation

Ayurvedic physicians did not have cortisol assays. They did not have randomised controlled trials or double-blind protocols. What they had was careful, disciplined, multigenerational observation of the human body in transition, and the intellectual rigour to codify what they found into a transmissible system.

They observed that the years around what we now call menopause involved a specific constellation of changes: heat and inflammation giving way to dryness and dispersal; the fire of midlife yielding to the wind of the later decades. They identified specific herbs that appeared to stabilise this transition. They used them consistently, across thousands of patients, over thousands of years.

Modern pharmacology has now characterised the compounds responsible, run the trials, and confirmed the mechanism.

But there is one thing the Vedic tradition understood that the clinical literature has been slower to articulate: what this transition is actually for.

In the Vedic view, the post-menopausal phase is not the aftermath of something lost. It is the beginning of the most powerful chapter of a woman’s life. The Pitta years (fire, production, outward direction) were necessary. They built things, raised things, drove things forward. But they also consumed. The Vata phase, when it is met with the right foundation, is not depletion. It is liberation.

The energy that was directed outward (toward reproduction, toward family, toward the relentless demands of the productive years) becomes available for something else. The Vedic texts describe this as the phase in which a woman becomes a teacher, a keeper of knowledge, a creative force operating from depth rather than urgency. Not softer. Clearer. Not less. Different.

The symptoms of the transition are real, and they deserve to be taken seriously and supported properly. But they are not the story. They are the passage between chapters.

Anne-Gaëlle’s view, informed by both a pharmacy training and years of engagement with Ayurvedic thought, is that this is the frame Vivana is built around. Not fixing what is broken. Supporting a body in transition so that what comes next (the clarity, the authority, the creative depth the Vedic tradition has always known is available on the other side) can actually be lived.

Better.

If the cortisol picture resonates (the wired-at-night, can’t-switch-off, tired-but-running pattern), read: High Cortisol Symptoms in Women Over 40: What Your Body Is Telling You

*If you are on HRT, the HRT Companion bundle is designed without phytoestrogenic input, while still supporting the cognitive layer through magnesium, omega-3 and gut-brain axis nutrients.

→

Explore Cortisol Control with KSM-66 at 200mg

The Core Reset System (Balance+ | Cortisol Control | Gut Harmony | Magnesium Pro | Omega-3)

Explore the HRT Companion System (Cortisol Control | Gut Harmony | Collagen Pro | Magnesium Pro | Omega-3)

Scientific references

1. Chandrasekhar K et al. A prospective, randomised double-blind, placebo-controlled study of safety and efficacy of KSM-66 ashwagandha root extract in reducing stress and anxiety. Indian J Psychol Med. 2012.
2. Langade D et al. Efficacy and safety of ashwagandha root extract in insomnia and anxiety. Medicine. 2019.
3. Wankhede S et al. Examining the effect of KSM-66 on physical performance and recovery. J Int Soc Sports Nutr. 2015.
4. Sharma AK et al. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients. J Altern Complement Med. 2018.
5. Gopal S et al. Effect of ashwagandha on menopausal symptoms in women. J Obstet Gynaecol Res. 2021.
6. Singh N et al. An overview of ashwagandha: a rasayana of Ayurveda. Afr J Tradit Complement Altern Med. 2011.
7. Lad V. Textbook of Ayurveda: Fundamental Principles. Ayurvedic Press. 2002.
8. Pole S. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone. 2006.
9. Pratte MA et al. An alternative treatment for anxiety: a systematic review of human trial results for ashwagandha. J Altern Complement Med. 2014.